TrialRheumatology international2021

Tofacitinib in the treatment of skin and musculoskeletal involvement in patients with systemic sclerosis, evaluated by ultrasound.

Rositsa Valerieva Karalilova et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.